iRobot Corp Valuation – July 2018 $IRBT
Company Profile (excerpt from Reuters): iRobot Corporation, incorporated on December 20, 2000, is a consumer robot company, which is engaged in designing and building robots. The Company’s portfolio of solutions features various technologies for the connected home and various concepts in mapping, navigation, mobility and artificial intelligence. The Company sells various products that are designed for use at home. Its consumer products focus on both indoor and outdoor cleaning applications. The Company offers multiple Roomba floor vacuuming robots. Roomba’s design allows it to clean under kick boards, beds and other furniture. The Company offers the Braava family of automatic floor mopping robots designed for hard surface floors. The Company’s trademarks include iRobot, Roomba, Scooba, ViPR, NorthStar, Create, iAdapt, Aware, Home Base, Looj, Braava, AeroForce, Mirra, vSLAM and Virtual Wall.
Downloadable PDF version of this valuation:
ModernGraham Valuation of IRBT – July 2018
Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?
What kind of Intelligent Investor are you?
Defensive Investor; must pass 6 out of the following 7 tests. | ||||
1. Adequate Size of the Enterprise | Market Cap > $2Bil | $2,239,045,575 | Pass | |
2. Sufficiently Strong Financial Condition | Current Ratio > 2 | 2.89 | Pass | |
3. Earnings Stability | Positive EPS for 10 years prior | Pass | ||
4. Dividend Record | Dividend Payments for 10 years prior | Fail | ||
5. Earnings Growth | Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end | 114.62% | Pass | |
6. Moderate PEmg Ratio | PEmg < 20 | 45.19 | Fail | |
7. Moderate Price to Assets | PB Ratio < 2.5 OR PB*PEmg < 50 | 4.96 | Fail | |
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor. | ||||
1. Sufficiently Strong Financial Condition | Current Ratio > 1.5 | 2.89 | Pass | |
2. Sufficiently Strong Financial Condition | Debt to NCA < 1.1 | 0.00 | Pass | |
3. Earnings Stability | Positive EPS for 5 years prior | Pass | ||
4. Dividend Record | Currently Pays Dividend | Fail | ||
5. Earnings Growth | EPSmg greater than 5 years ago | Pass |
Stage 2: Determination of Intrinsic Value
EPSmg | $1.77 |
MG Growth Estimate | 10.46% |
MG Value | $52.18 |
Opinion | Overvalued |
MG Grade | C |
MG Value based on 3% Growth | $25.72 |
MG Value based on 0% Growth | $15.08 |
Market Implied Growth Rate | 18.34% |
Current Price | $80.16 |
% of Intrinsic Value | 153.63% |
iRobot Corporation is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the poor dividend history, and the high PEmg and PB ratios. The Enterprising Investor is only concerned with the lack of dividends. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.
As for a valuation, the company appears to be Overvalued after growing its EPSmg (normalized earnings) from $1.05 in 2014 to an estimated $1.77 for 2018. This level of demonstrated earnings growth does not support the market’s implied estimate of 18.34% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value below the price.
At the time of valuation, further research into iRobot Corporation revealed the company was trading above its Graham Number of $28.73. The company does not pay a dividend. Its PEmg (price over earnings per share – ModernGraham) was 45.19, which was below the industry average of 53.59, which by some methods of valuation makes it one of the most undervalued stocks in its industry. Finally, the company was trading above its Net Current Asset Value (NCAV) of $7.4.
iRobot Corporation receives an average overall rating in the ModernGraham grading system, scoring a C.
Stage 3: Information for Further Research
Net Current Asset Value (NCAV) | $7.40 |
Graham Number | $28.73 |
PEmg | 45.19 |
Current Ratio | 2.89 |
PB Ratio | 4.96 |
Current Dividend | $0.00 |
Dividend Yield | 0.00% |
Number of Consecutive Years of Dividend Growth | 0 |
Useful Links:
ModernGraham tagged articles | Morningstar |
Google Finance | MSN Money |
Yahoo Finance | Seeking Alpha |
GuruFocus | SEC Filings |
Most Recent Balance Sheet Figures
Balance Sheet Information | 6/1/2018 |
Total Current Assets | $348,446,000 |
Total Current Liabilities | $120,723,000 |
Long-Term Debt | $0 |
Total Assets | $596,781,000 |
Intangible Assets | $152,398,000 |
Total Liabilities | $138,740,000 |
Shares Outstanding (Diluted Average) | 28,337,000 |
Earnings Per Share History
EPS History | |
Next Fiscal Year Estimate | $2.18 |
Dec2017 | $1.77 |
Dec2016 | $1.48 |
Dec2015 | $1.47 |
Dec2014 | $1.25 |
Dec2013 | $0.94 |
Dec2012 | $0.61 |
Dec2011 | $1.44 |
Dec2010 | $0.96 |
Dec2009 | $0.13 |
Dec2008 | $0.03 |
Dec2007 | $0.36 |
Dec2006 | $0.14 |
Dec2005 | $0.11 |
Dec2004 | $0.01 |
Dec2003 | -$0.79 |
Dec2002 | -$2.00 |
Dec2001 | -$0.50 |
Earnings Per Share – ModernGraham History
EPSmg History | |
Next Fiscal Year Estimate | $1.77 |
Dec2017 | $1.51 |
Dec2016 | $1.30 |
Dec2015 | $1.19 |
Dec2014 | $1.05 |
Dec2013 | $0.90 |
Dec2012 | $0.80 |
Dec2011 | $0.79 |
Dec2010 | $0.42 |
Dec2009 | $0.15 |
Dec2008 | $0.15 |
Dec2007 | $0.13 |
Dec2006 | -$0.16 |
Dec2005 | -$0.42 |
Dec2004 | -$0.67 |
Dec2003 | -$0.90 |
Dec2002 | -$0.80 |
Recommended Reading:
Other ModernGraham posts about the company
iRobot Corp Valuation – Initial Coverage $IRBT
Other ModernGraham posts about related companies
Disclaimer:
The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.